Previous 10 | Next 10 |
2023-10-05 13:49:37 ET Shares of uniQure (NASDAQ: QURE) were up more than 8% as of 1 p.m. after rising as much as 14% earlier in the day. So far this year, the biotech stock is down more than 70%. The gene-editing therapy company said it plans to cut back staff and progr...
2023-10-05 07:59:37 ET More on uniQure uniQure: AMT-130 Data And Other Catalysts In H2 2023 uniQure: The AMT-130 Readout uniQure cleared to start U.S. trial for gene therapy Seeking Alpha’s Quant Rating on uniQure Historical earnings data for u...
~ Reduction of 28% of workforce not related to HEMGENIX ® manufacturing obligations; Total cost savings of $180 million to extend cash runway into second quarter of 2027 ~ ~ Discontinuing investments in more than half of research and technology projects, centralizing op...
2023-10-04 17:50:03 ET Gainers: Prime Medicine ( NASDAQ: PRME ) +5% . uniQure ( QURE ) +5% . Aclaris Therapeutics ( ACRS ) +4% . ALX Oncology Holdings ( ALXO ) +3% . Aurora Innovation ( AUR ) +3% . Losers: MaxCy...
2023-09-21 14:37:34 ET More on uniQure Seeking Alpha’s Quant Rating on uniQure Historical earnings data for uniQure Financial information for uniQure uniQure: AMT-130 Data And Other Catalysts In H2 2023 uniQure: The AMT-130 Readout For ...
2023-09-07 06:50:56 ET Summary uniQure has made progress in advancing its gene therapy candidates, including AMT-130 for Huntington's disease; additional data from phase I/II study expected Q4 of 2023. Interim data from the phase I/II study of AMT-130 showed it was safe and tolera...
2023-09-05 13:10:58 ET Shares of uniQure (NASDAQ: QURE) were down more than 11% as of 1:06 p.m. on Tuesday after the gene-therapy company announced that the Food and Drug Administration (FDA) had cleared its investigational new drug (IND) application for AMT-260, a treatment for...
2023-09-05 10:38:09 ET More on uniQure Seeking Alpha’s Quant Rating on uniQure Historical earnings data for uniQure Financial information for uniQure uniQure: The AMT-130 Readout Biggest stock movers today: Patterson Companies, Peloton Interact...
2023-09-05 10:11:48 ET More on Airbnb Seeking Alpha’s Quant Rating on Airbnb Historical earnings data for Airbnb Financial information for Airbnb Airbnb: S&P 500 Addition Strengthens Its Robust Growth Story Airbnb: Upgrading To Hold, Headwi...
2023-09-05 10:00:14 ET More on Health Care Select Sector SPDR Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Dividend scorecard for Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) ...
News, Short Squeeze, Breakout and More Instantly...
~ uniQure maintains preferential access to industry-leading manufacturing capabilities to support its pipeline of gene therapy candidates ~ ~ Immediate reduction in cash burn, projected to save $40 million annually ~ LEXINGTON, Mass. and AMSTERDAM, July 23, 2024 (GLOBE NEWSWIRE) -...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 2.5% to $131.38 on volume of 280,159,738 shares Maxeon Solar Technologies Ltd. (MAXN) fell 8.1% to $0.248 on volume of 217,585,873 shares Tesla Inc. (TSLA) rose 3.7% to $262.33 on volume of 159,323,492 s...